The Federal Register

Request for Nominations of Candidates To Serve on the Advisory Committee on Immunization Practices, Centers for

Fri, Dec 9 2005 11:00:00 GMT

The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the Advisory Committee on Immunization Practices (ACIP). This committee provides advice and guidance to the Secretary of the Department of Health and Human Services (HHS), and the Director, CDC, regarding the most appropriate application of antigens and related agents for effective communicable disease control in the civilian population. The committee reviews and reports regularly on immunization practices and recommends improvements in the national immunization efforts.

The committee also establishes, reviews, and as appropriate, revises the list of vaccines for administration to children eligible to receive vaccines through the Vaccines for Children (VFC) Program.

Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee's objectives. Nominees will be selected based upon expertise in the fi

Agency Information Collection Activities: Proposed Collection; Comment Request

Fri, Dec 9 2005 11:00:00 GMT

Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget

Fri, Dec 9 2005 11:00:00 GMT

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Fri, Dec 9 2005 11:00:00 GMT

Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole Nitrate Cream; Miconazole Nitrate Lotion; Miconazole

Fri, Dec 9 2005 11:00:00 GMT

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADA provides for topical use of miconazole nitrate as a spray or lotion on dogs and cats for the treatment of certain fungal infections.

Oral Dosage Form New Animal Drugs; Sulfadimethoxine Soluble Powder

Fri, Dec 9 2005 11:00:00 GMT

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Cross Vetpharm Group Ltd. The ANADA provides for the oral use of sulfadimethoxine soluble powder to create a solution administered as a drench to cattle or in the drinking water of chickens, turkeys, or cattle for the treatment of coccidiosis or various bacterial diseases.

Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products Containing Coal Tar and Menthol for Over-the-Counter

Fri, Dec 9 2005 11:00:00 GMT

The Food and Drug Administration (FDA) is issuing a proposed rule to amend the final monograph (FM) for overthecounter (OTC) dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8 percent coal tar solution and 1.5 percent menthol in a shampoo drug product to control dandruff. FDA is issuing this proposed rule after considering information submitted in a citizen petition. This proposal is part of FDA's ongoing review of OTC drug products.

Food Ingredient Solutions, LLC; Filing of Color Additive Petition

Fri, Dec 9 2005 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing that Food Ingredient Solutions, LLC, has filed a petition proposing that the color additive regulations be amended to expand the use of sodium copper chlorophyllin to include foods generally (with the exception of meat, poultry, fish, and standardized foods) and to include fescue grass as a permitted source.

Solicitation of New Safe Harbors and Special Fraud Alerts

Fri, Dec 9 2005 11:00:00 GMT

In accordance with section 205 of the Health Insurance Portability and Accountability Act (HIPAA) of 1996, this annual notice solicits proposals and recommendations for developing new and modifying existing safe harbor provisions under the Federal antikickback statute (section 1128B(b) of the Social Security Act), as well as developing new OIG Special Fraud Alerts.